Showing results (121-130 of 1,403) with videos related to

Sort By:
Pageof 141
United European Gastroenterology Journal|July 6, 2021
Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progressionEsther Klaver, Angela Bureo Gonzalez, Nahid Mostafavi, et al.
United European Gastroenterology Journal|November 22, 2022
German guideline diverticular disease/diverticulitis: Part I: Methods, pathogenesis, epidemiology, clinical characteristics (definitions), natural course, diagnosis and classificationWolfgang Kruis, Christoph-Thomas Germer, Stephan Böhm, et al.
United European Gastroenterology Journal|July 24, 2020
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseLeonard Kaps, Christian Labenz, Peter R Galle, et al.
United European Gastroenterology Journal|April 17, 2023
Metabolic-associated fatty liver disease is associated with acute pancreatitis with more severe course: Post hoc analysis of a prospectively collected international registrySzilárd Váncsa, Zoltán Sipos, Alex Váradi, et al.
United European Gastroenterology Journal|May 4, 2023
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort studyBélène Podmore, Dominik Beier, Johan Burisch, et al.
United European Gastroenterology Journal|May 8, 2023
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome-wide association studyKatharina Sophie Seeling, Leonida Hehl, Mara Sophie Vell, et al.
United European Gastroenterology Journal|August 12, 2020
Histologic parameter score does not predict short-term survival in severe alcoholic hepatitisMargaux Dubois, Amedeo Sciarra, Eric Trépo, et al.
United European Gastroenterology Journal|August 5, 2020
Endoscopic treatment of large symptomatic colon lipomas: A systematic review of efficacy and safetyMichiel Bronswijk, Anne-Marie Vandenbroucke, Peter Bossuyt
United European Gastroenterology Journal|August 11, 2020
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre studyFabio Salvatore Macaluso, Walter Fries, Sara Renna, et al.
United European Gastroenterology Journal|August 19, 2020
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort studyNathaniel Aviv Cohen, Nikolas Plevris, Uri Kopylov, et al.
Pageof 141